m+Medelevator.RU
← Поиск публикаций
Journal of oral microbiology · 2025

Preventive effects of Weissella cibaria CMU on the progression of periodontitis in a rat model.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Do Kyung-Hyo, Boo Soyoung, You Rayoung, Kim Sanggu, Kim Soochong, Seo Kwang-Won, Kang Mi-Sun, Lee Wan-Kyu

Аннотация

BACKGROUND: Periodontitis is a widespread chronic inflammatory disease impacting 20-50% of the global population.

METHODS: This study evaluated the effects of Weissella cibaria CMU (CMU) on preventing the progression of periodontitis in a rat model. Periodontitis was induced by injecting lipopolysaccharide into the palatal gingiva around the first and second maxillary molars. CMU was then administered at three concentrations (low: 2 × 107 CFU/rat/day; mid: 2 × 108 CFU/rat/day; high: 2 × 109 CFU/rat/day) for 14 days to assess its ability to prevent further periodontal damage.

RESULTS: The administration of CMU significantly improved gingivitis and plaque indices in a dose-dependent manner. Macroscopic analysis and micro-computed tomography showed a dose-dependent reduction in alveolar bone loss in the CMU groups. Although histopathological analysis indicated a decrease in bone loss, statistical significance was not achieved in the high-dose group. Pro-inflammatory mediators such as TNF-α, IL-6, MMP-1, and MMP-9 were suppressed in a dose-dependent manner in the CMU groups. Additionally, mid- and high-dose CMU increased the relative abundance of Weissella in the oral microbiome.

CONCLUSIONS: CMU can influence the oral microbiome, reduce inflammatory mediators, and alleviate histological changes in periodontal tissue, highlighting its potential as a probiotic strain for preventing periodontitis.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты